- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04211935
Identification of Best Postoperative Analgesia Method Following a Minimally Invasive Repair of Pectus Excavatum ((MIRPE))
The Use of Video-assisted Intercostal Nerve Cryoablation, Erector Spinae Block, and Thoracic Epidural for Postoperative Analgesia After Minimally Invasive Repair of Pectus Excavatum
Study Overview
Status
Conditions
Detailed Description
Pectus excavatum deformity is a common condition in a pediatric surgical practice. While MIRPE provides excellent cosmetic results and is associated with shorter operative time and lower intraoperative blood loss, the immediate correction of the concave deformity with a metal bar places patients in a difficult pain control situation. While multiple postoperative analgesia modalities have been studied, there is still a need for a large, prospective, randomized trial that is appropriately powered to evaluate the best pain control modality after MIRPE. Of the clinically appropriate interventions, ESB and INC have been shown to have comparable LOS after the operation, especially when employed as part of an enhanced recovery pathway (ERP) bundle. Comparing these newer analgesia modalities to the more established PCA approach may help identify the most effective postoperative pain control approach that maximizes the safety profile while minimizing the use of narcotic pain medications after MIRPE.
The investigators propose a prospective randomized trial evaluating the effectiveness of INC, PCA and ESB with continuous local anesthetic infusion via a pain pump delivery system. All groups will follow a multimodal enhanced recovery pathway. Groups will different only in the use of INC, PCA, or ESB.
Since previous studies have reported similarly short LOS for both ESB and INC, but no prospective, direct comparisons of these techniques have been done, we believe comparing these two groups to the more established PCA modality will further advance the field of post MIRPE pain management by providing precise estimates of length of stay (LOS), hospital resource utilization, and other important outcomes that have not received sufficient attention including pain, quality of life, resumption of activities of daily living, and a rigorous survey for potential adverse outcomes. The investigators specifically hypothesize that because of the long-term analgesia of up to 2-3 months, the INC group may experience not only shorter LOS but decreased narcotic use than the ESB and PCA groups, and also improved quality of life, with fewer encounters in the postoperative period (30 days) for pain related concerns.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jose L Diaz-Miron, MD
- Phone Number: 720-777-6571
- Email: jose.diaz-miron@childrenscolorado.org
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- Recruiting
- Children's Hospital Colorado
-
Contact:
- Jose L Diaz-Miron, MD
- Phone Number: 720-777-6571
- Email: jose.diaz-miron@childrenscolorado.org
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- All patients with a pectus excavatum deformity that will undergo a MIRPE procedure will be included in the study.
Exclusion Criteria:
- < 13 years old
- > 18 years old
- chronic narcotic preoperative use
- previous repair of pectus excavatum deformity
- previous thoracic surgery
- pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Patient Controlled Analgesia
This technique involves connecting a patient controlled analgesia pump to the intravenous line.
The patient has the ability to push a button to obtain a predetermined dose of an intravenous opioid with a set lockout time period to minimize the potential for over sedation.
PCA pumps will be connected to the intravenous line of the patient at the end of the MIRPE operation.
anesthesiologists with experience in regional anesthesia.
|
A commercially available PCA pump will be connected to the patient's intravenous line at the end of the MIRPE operation.
|
Experimental: Erector Spinae Block
This method consists of the anesthesiologist placing two catheters on each side of the vertebrae which then delivers pain medicine continuously via pumps for 2-3 days post-surgery.
|
Pediatric anesthesiologists will place ESB at the time of the MIRPE operation if study participants are randomized into this group.
|
Experimental: Intercostal Nerve Cryoablation
The INC technique relies on multilevel freezing of the intercostal neurovascular bundle intraoperatively to block sensation and pain for approximately 2 months postoperatively.
Trained pediatric surgeons will perform the INC at the time of a MIRPE procedure.
|
Pediatric surgeons will perform INC during the MIRPE operation if they are randomized to this group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Length of Stay
Time Frame: 24 months
|
The investigators will measure the total length of stay following the operation until discharge from the hospital.
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Total intravenous and oral opioid use
Time Frame: 24 months
|
The investigators will quantify the total opioid usage during the hospitalization and also at home and will convert the total results to morphine equivalences for standardization.
|
24 months
|
Postoperative pain
Time Frame: 24 months
|
The investigators will use reported pain scores to quantify this measure.
Scale of 0-10 (0=no pain, 10=worst pain experienced).
The investigators will also ask about chest numbness for those in the INC group and will report it on a 0-100% scale (0%=no numbness at all, 100%=completely numb or absent of any sensation).
|
24 months
|
Quality of life after MIRPE
Time Frame: 24 months
|
The investigators will use a questionnaire to identify if patients are back to baseline and performing their activities of daily living.
The investigators will also ask about resumption of any sports related activities after the appropriate postoperative restriction timeframe has passed.
This will be a multiple choice questionnaire that will record if 1) they are back to baseline, 2) they are almost back to baseline, 3) they are not back to baseline at all.
The investigators will also ask in a multiple choice manner if they have resumed their activities of daily living.
The possible answers will be 1) Yes, 2) Incorporating some of the preoperative activities, 3) No
|
24 months
|
Complications
Time Frame: 24 months
|
The investigators will ask patients about postoperative complications when they are at home.
We will also refer back to the chart for any complications that occur during the initial postoperative period or those that have required a readmission after the initial operation.
|
24 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Natasha Corbitt, MD, Safety Officer--University of Texas Southwestern
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-2794
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain, Postoperative
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
Ankara City Hospital BilkentRecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | SternotomyTurkey
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Aydin Adnan Menderes UniversityCompleted
-
Aydin Adnan Menderes UniversityCompletedAcute Postoperative Pain | Chronic Postoperative PainTurkey
-
Maimonides Medical CenterCompletedPOSTOPERATIVE PAINUnited States
-
University Hospital, AntwerpUnknown
-
VA Office of Research and DevelopmentRecruitingTotal Knee Arthroplasty (Postoperative Pain) | Total Hip Arthroplasty (Postoperative Pain)United States
-
VA Office of Research and DevelopmentCompletedTotal Knee Arthroplasty (Postoperative Pain) | Total Hip Arthroplasty(Postoperative Pain)United States
Clinical Trials on Use of PCA
-
Tel-Aviv Sourasky Medical CenterUnknownPost Operative PainIsrael
-
Boston Scientific CorporationRecruitingCancer | ProstateUnited States
-
Hadassah Medical OrganizationCompleted
-
Children's Mercy Hospital Kansas CityTerminatedProspective Trial: Pain Management After Pectus Excavatum Repair, Epidural Versus PCA (PectusEpiPCA)Pectus ExcavatumUnited States
-
Assiut UniversityUnknown
-
University of Sao Paulo General HospitalUnknownKnee Osteoarthritis | Metabolic Disease
-
Nanjing Medical UniversityCompleted
-
SOTIO a.s.CompletedProstate CancerCzechia
-
Boston Children's HospitalUnknownPediatric Rheumatological Condition (i.e., Arthritis, SLE, Kawasaki's Disaese)United States